Sleep Duration for Asthma
(AIMS Trial)
Trial Summary
What is the purpose of this trial?
Urban children with asthma are at high risk for short sleep, due to an environment that jeopardizes both sleep and asthma management. Further, urban children with asthma suffer from altered immune balance, a key biological process contributing to individual differences in asthma morbidity and sleep health. In the proposed research, the researchers will examine the effects of shortened and recovery sleep on immune balance and associated changes in lung function in urban children with allergic asthma through an experimental design.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it requires participants to have a current prescription for an asthma controller medicine. It seems likely that you will need to continue your asthma medication during the trial.
What data supports the effectiveness of the treatment Shortened Sleep, Stabilized Sleep for asthma?
Is it safe to change sleep patterns for asthma treatment?
How does sleep duration treatment differ from other asthma treatments?
This treatment focuses on adjusting sleep duration to manage asthma symptoms, which is different from traditional asthma treatments that typically involve medications like inhalers. It explores the relationship between sleep patterns and asthma control, offering a novel approach by potentially improving asthma symptoms through better sleep management.12389
Research Team
Daphne Koinis-Mitchell, PhD
Principal Investigator
Rhode Island Hospital
Eligibility Criteria
This trial is for urban children aged 7-10 with allergic asthma, who sleep 9-11 hours daily and are on asthma control medicine. They must have a positive allergy test, speak English at home, and live in certain urban areas. Kids can't join if they've had recent severe asthma issues, other lung or immune diseases, ADHD on stimulants, advanced puberty stages, used steroids recently or have significant developmental or learning problems.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Stabilized Sleep
Participants follow their usual bed time schedule for 1 week
Shortened Sleep
Participants follow a shortened sleep schedule, going to bed 90 minutes later than usual
Recovery Sleep
Participants follow a recovery sleep schedule, increasing time in bed by 1.5 hours
Follow-up
Participants are monitored for changes in immune balance and lung function
Treatment Details
Interventions
- Shortened Sleep
- Stabilized sleep
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rhode Island Hospital
Lead Sponsor
Brown University
Collaborator
University of Mississippi Medical Center
Collaborator
University of Colorado, Denver
Collaborator